Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
about
Integrin alphaVbeta3 Binds to the RGD motif of glycoprotein B of Kaposi's sarcoma-associated herpesvirus and functions as an RGD-dependent entry receptorKSHV-Mediated Angiogenesis in Tumor ProgressionEnzyme Inhibition by Allosteric Capture of an Inactive ConformationKSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane DynamicsThe ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirusKaposi sarcoma herpes virus latency associated nuclear antigen protein release the G2/M cell cycle blocks by modulating ATM/ATR mediated checkpoint pathwayEpidemiology of Kaposi's sarcoma-associated herpesvirus in Asia: Challenges and opportunities.Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.De novo infection with rhesus monkey rhadinovirus leads to the accumulation of multiple intranuclear capsid species during lytic replication but favors the release of genome-containing virions.Phosphorylation of eukaryotic translation initiation factor 4B (EIF4B) by open reading frame 45/p90 ribosomal S6 kinase (ORF45/RSK) signaling axis facilitates protein translation during Kaposi sarcoma-associated herpesvirus (KSHV) lytic replicationPRICE: software for the targeted assembly of components of (Meta) genomic sequence dataAberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction.Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus.The gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 modulate the Toll-like receptor-induced proinflammatory cytokine response.Host transcript accumulation during lytic KSHV infection reveals several classes of host responsesMolecular biology of KSHV in relation to AIDS-associated oncogenesis.CD8+ T cell evasion mandates CD4+ T cell control of chronic gamma-herpesvirus infection.The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.Kaposi's sarcoma-associated herpesvirus ORF45 mediates transcriptional activation of the HIV-1 long terminal repeat via RSK2.KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.BALB/c mice immunized with a combination of virus-like particles incorporating Kaposi sarcoma-associated herpesvirus (KSHV) envelope glycoproteins gpK8.1, gB, and gH/gL induced comparable serum neutralizing antibody activity to UV-inactivated KSHV.Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation.Viral latency and its regulation: lessons from the gamma-herpesviruses.Kaposi's sarcoma-associated herpesvirus virion-induced transcription activation of the ORF50 immediate-early promoterThe lytic transcriptome of Kaposi's sarcoma-associated herpesvirus reveals extensive transcription of noncoding regions, including regions antisense to important genes.Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replicationLatent KSHV infection of endothelial cells induces integrin beta3 to activate angiogenic phenotypesEstablishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.The RBP-Jκ binding sites within the RTA promoter regulate KSHV latent infection and cell proliferation.Nuclear import of cytoplasmic poly(A) binding protein restricts gene expression via hyperadenylation and nuclear retention of mRNA.Kaposi's sarcoma-associated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication.The latency-associated nuclear antigen of Kaposi sarcoma-associated herpesvirus induces B cell hyperplasia and lymphoma.Noncoding RNPs of viral originInfection of dendritic cells by a gamma2-herpesvirus induces functional modulationActive lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells.Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines.The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells.Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection.Expanding the role of Drosha to the regulation of viral gene expression.Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
P2860
Q24301712-46600C31-9A0C-41DC-A592-4C4A8DD1C829Q26742030-46918A65-CFCC-46A4-A5A3-BE95BC9D57DBQ27670647-8E75C19D-E2CD-4140-A337-FA759538CD5EQ28072153-CF44F8E9-E708-47E6-B13B-E52C4A5D7C21Q28267511-3CCAE24B-C2A0-4886-AD75-61ECFE23FBCCQ28540116-FB9148FF-85CA-4B96-BD48-EB2488A50270Q30248457-2073F09F-1B62-4D1E-A855-304AC3EE8014Q30311122-69A2EF74-8AEC-46AC-B090-3E117E2E0914Q30311978-AB149462-7117-484D-BA47-4B5CB31C7C94Q30423529-D559BAE8-CCDE-4F98-BD63-091550E123FDQ30611167-5B57EFFF-FCDA-47C5-ACD5-AC3A25290E0CQ30863867-00AC5A16-F039-4A54-833E-FB8EEE6F8B46Q31156919-05E607B4-6614-41F0-B995-94143AC5BDDFQ31162657-D0115DD2-B963-44B2-8ABD-F309C5295BB8Q33295395-5F8D0D4F-114F-465E-94D4-F893DC79D845Q33560572-051D8D10-E261-4F4D-8A14-CE15470B68C0Q33585365-618247BD-5E80-44D4-96E1-1F16ED7C43DCQ33598569-A05CBA07-DB34-447C-BAE1-C48532D594DEQ33743857-55ECEA34-63F3-4F4D-840C-AAA3ECA66819Q33761091-72C39C64-3522-42FD-922A-015866E598C5Q33798426-4613BCE1-F623-44B6-8722-3C33557B3F3AQ34005284-E3F9813A-A848-4D03-8A23-9D8560D2EBD4Q34039189-4095DA7E-AE21-4D2E-BA00-31BD16D2C174Q34045753-8488F0F7-BEB1-4F1B-A0D9-094D42647D6AQ34046103-CE87C8AD-E8E3-464B-92A7-192241299A81Q34059252-1AB02D73-979F-499E-9763-75A64A30E178Q34102739-0DC91A35-B02C-4084-999B-00EF572835E6Q34124015-9660CEEC-7044-4192-BD37-1CCB8D14C26AQ34130213-5E1D2359-186E-438C-B50A-057244DBA2E2Q34190177-0F2BBB32-CA91-4418-8366-49DBD4D5F49FQ34261905-F9C81034-7211-4FA4-B329-880EEDA274A7Q34391203-C8297A2D-CD9D-4DB2-A1A4-306B29B2B651Q34578041-F971BB27-6412-4DA6-A8C7-64309B8D9C67Q34602160-4D454328-FE31-45E9-802A-C690C365EBF9Q34627227-9FB8852D-C46B-4915-8734-1646B6875EBFQ34733560-CAE84B06-0E71-4552-AA09-2AF5B827DD93Q35071118-BE49630B-4C7B-4D4D-A400-6931ADB00533Q35075128-D29AFF28-A268-4D6F-AE0B-DBBF42D1FB8AQ35090908-03E297FD-7D8E-4346-BEB3-C06AE8499194Q35111065-DE26486D-CD47-4447-9F67-1E330DA19166
P2860
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@en
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@nl
type
label
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@en
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@nl
prefLabel
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@en
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@nl
P2093
P2860
P1433
P1476
Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.
@en
P2093
Jill T Bechtel
Joshua Hvidding
Yuying Liang
P2860
P304
P356
10.1128/JVI.77.11.6474-6481.2003
P407
P577
2003-06-01T00:00:00Z